Stock Events

Stock Events

Viskase 

$5.75
10
+$0+0% Tuesday 19:08

Statistics

Day High
7.07
Day Low
6.55
52W High
12.7
52W Low
3
Volume
163,127
Avg. Volume
-
Mkt Cap
426.92M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Oct 19
$12
Mar 19
$6
Sep 17
$15
Dec 16
$15
Dec 15
$25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

9NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.01
-0.01
-0
0
Expected EPS
0
Actual EPS
-0.01

Financials

-1,911.54%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
52,000Revenue
-994,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ENZN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences is a biopharmaceutical company that competes in the development of drugs for infectious diseases, a market Enzon Pharmaceuticals also targets.
AMGEN
AMGN
Mkt Cap178B
Amgen is a biotech firm focusing on novel therapeutics, including treatments for serious illnesses, overlapping with Enzon's therapeutic areas.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb is involved in discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, similar to Enzon's mission.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a global pharmaceutical company with a broad range of drugs and vaccines, competing across several of the same therapeutic areas as Enzon.
Merck
MRK
Mkt Cap277.02B
Merck operates in the pharmaceutical sector, focusing on drugs for conditions that Enzon Pharmaceuticals also aims to treat, making them direct competitors.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie is a research-based biopharmaceutical company with a significant focus on developing treatments for serious diseases, competing with Enzon in drug development.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals specializes in the invention of medicines for serious medical conditions, directly competing with Enzon in the biopharmaceutical field.
Biogen
BIIB
Mkt Cap27.62B
Biogen is a biotechnology company that develops therapies for neurological and neurodegenerative diseases, competing with Enzon in the biopharmaceutical market.
Vertex Pharmaceuticals
VRTX
Mkt Cap107.83B
Vertex Pharmaceuticals is known for creating new possibilities in medicine to cure diseases and improve people's lives, competing with Enzon in drug innovation.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including areas where Enzon operates.

About

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Show more...
CEO
Mr. Thomas Dale Davis
Employees
1
Country
United States
ISIN
US2939048011

Listings

OTCM
US
ENZND
STU
DE
EZ1.STU
OTC Link
US
ENZN

0 Comments

Share your thoughts

FAQ

What is Viskase stock price today?▼
The current price of ENZN is $5.75 USD — it has increased by +0% in the past 24 hours. Watch Viskase stock price performance more closely on the chart.
What is Viskase stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Viskase stocks are traded under the ticker ENZN.
Is Viskase stock price growing?▼
ENZN stock has fallen by -28.09% compared to the previous week, the month change is a -4.12% fall, over the last year Viskase has showed a -42.47% decrease.
What is Viskase market cap?▼
Today Viskase has the market capitalization of 426.92M
What were Viskase earnings last quarter?▼
ENZN earnings for the last quarter are -0.01 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Viskase revenue for the last year?▼
Viskase revenue for the last year amounts to 52,000 USD.
What is Viskase net income for the last year?▼
ENZN net income for the last year is -994,000 USD.
Does Viskase pay dividends?▼
Yes, ENZN dividends are paid annual. The last dividend per share was 12 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Viskase have?▼
As of May 06, 2026, the company has 1 employees.
In which sector is Viskase located?▼
Viskase operates in the Health & Wellness sector.
When did Viskase complete a stock split?▼
The last stock split for Viskase was on March 25, 2026 with a ratio of 1:100.
Where is Viskase headquartered?▼
Viskase is headquartered in Lombard, United States.